SUNNYVALE, Calif., June 05, 2024 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ:ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, announced today that the U.S. Food and Drug Administration (FDA) cleared a labeling revision for da Vinci X and Xi specific to radical prostatectomy. This clearance was based on real-world evidence (RWE) collected from 2007 to 2014 that demonstrates overall five- to 10-year survival following robotic-assisted radical prostatectomy is ...

The most recent trading session ended with Intuitive Surgical, Inc. (ISRG) standing at $403.39, reflecting a +1.25% shift from the previouse trading day's closing. The stock exceeded the S&P 500, which registered a loss of 0.6% for the day. Elsewhere, the Dow saw a downswing of 0.86%, while the tech-heavy Nasdaq depreciated by 1.08%.Coming into today, shares of the company had gained 7.18% in the past month. In that same time, the Medical sector gained 1.32%, while the S&P 500 gained 3.15%.Analysts and inve ...

While the biotechnology sector may receive most of the attention under the broad healthcare umbrella, investors ought to spare some love for medical technology stocks. The enterprises undergirding these securities offer tremendously positive potential for overall patient outcomes.Fundamentally, the sector enjoys decent growth projections despite being a relatively mature industry. According to BCC Research, the global medical device technology ecosystem reached a valuation of $639.1 billion in 2021. Experts ...

Intuitive Surgical (ISRG) witnessed strong momentum in the year-to-date period. Shares of the company have gained 20% compared with 8.2% growth of the industryin the same time frame. The S&P 500 Composite has risen 11.5% during the same period.With healthy fundamentals and strong growth opportunities, this Zacks Rank #3 (Hold) company appears to be a solid wealth creator for its investors at the moment. ISRG’s earnings surpassed the Zacks Consensus Estimate in all the trailing four quarters with an average ...

In the latest market close, Intuitive Surgical, Inc. (ISRG) reached $404.85, with a +1.62% movement compared to the previous day. This move outpaced the S&P 500's daily gain of 0.7%. At the same time, the Dow added 0.01%, and the tech-heavy Nasdaq gained 1.1%.Shares of the company witnessed a gain of 6.77% over the previous month, beating the performance of the Medical sector with its gain of 3.27% and the S&P 500's gain of 4.03%.The investment community will be paying close attention to the earnings perfor ...

Brokerage Recommendations and ABR - Intuitive Surgical Inc (ISRG) currently has an Average Brokerage Recommendation (ABR) of 1.70, which approximates between Strong Buy and Buy on a scale of 1 to 5 [1] - The ABR is derived from 23 brokerage firm recommendations, with 14 Strong Buy (60.9%) and 2 Buy (8.7%) ratings [1] - Brokerage recommendations often exhibit a strong positive bias, with firms assigning five Strong Buy recommendations for every Strong Sell recommendation [2] - The ABR should not be confused with Zacks Rank, as the former is based solely on brokerage recommendations while the latter is driven by earnings estimate revisions [4][5] Zacks Rank and Earnings Estimates - Zacks Rank is a proprietary stock rating tool that categorizes stocks into five groups and has a strong track record of predicting near-term stock price movements [3] - The Zacks Rank is updated frequently to reflect changes in earnings estimates, making it a timely indicator of future price movements [5] - Intuitive Surgical has a Zacks Rank 3 (Hold) due to unchanged consensus earnings estimates and other factors related to earnings estimates [6] Investment Considerations for ISRG - The Zacks Consensus Estimate for Intuitive Surgical's current year earnings has remained unchanged at $6.26 over the past month [6] - Analysts' steady views on the company's earnings prospects suggest the stock may perform in line with the broader market in the near term [6] - While the ABR suggests buying Intuitive Surgical, the Zacks Rank indicates a more cautious approach may be prudent [6]

Shares of Intuitive Surgical (ISRG) scaled a new 52-week high of $408.39 on May 22, 2024, before closing the session at $400.90.This Zacks Rank #3 (Hold) company’s shares have risen 18.8% year to date compared with 8.9% growth of the industry. The S&P 500 composite rose 12.1% during the same time frame.Over the past five years, the company’s earnings increased at a CAGR of 6.5% compared with the industry’s 9.9% growth. The company’s long-term growth rate of 16.1% compares with the industry’s 22.5%. Intuitiv ...

Automation continues to be a key driving force of technological innovation in the 21st century. Older industrial sectors have relied on automation for driving efficiencies across the use of various equipment. Technology companies have, of course, employed varying levels of software automation to create new tools and spur productivity. Healthcare services companies have also found a use for automation, particularly in the context of surgery. The robotics sector has been at the epicenter of forces driving aut ...

Intuitive Surgical, Inc. (NASDAQ:ISRG) BofA Securities 2024 Health Care Conference May 15, 2024 11:00 AM ET Company Participants Brian King - Head of Investor Relations Brandon Lamm - Investor Relations Conference Call Participants Travis Steed - Bank of America Travis Steed We've got Intuitive Surgical. Got, Brian King, Vice President Treasurer, Head of Investor Relations. We also have Brandon Lamm up here from Investor Relations as well. Thanks for joining us. Brian King Thank you for having us. Brandon L ...

This company's potential far outweighs its risks.Many companies don't last more than five years; many more have trouble reaching the age of 10. And those that can last 30 years or more are rare. Intuitive Surgical (ISRG 2.61%) is close to accomplishing that sort of longevity.Created in 1995, the medical device specialist hasn't just survived over the years, it has thrived. That's not to say Intuitive Surgical hasn't faced issues, but even with a range of headwinds coming its way, the healthcare pioneer shou ...